You have 3 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

esophageal cancer; neoadjuvant; efficiency

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunochemotherapy in Esophageal Cancer

Recruiting
  • Esophageal Cancer
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Nov 24, 2022

    Sintilimab and Anlotinib in Combination With Chemo Trial in Xi'an (Sintilimab and anlotinib in combination with chemo)

    Completed
    • Sintilimab and Anlotinib in Combination With Chemotherapy
    • Sintilimab and anlotinib in combination with chemotherapy
    • Xi'an, Shanxi, China
    • +1 more
    Aug 27, 2023

    Esophageal Cancer Trial in Wuhan

    Recruiting
    • Esophageal Cancer
      • Wuhan, Hubei, China
        Renmin hosptial of Wuhan University
      Jun 7, 2023

      Esophageal Squamous Cell Cancer Trial in Beijing (Toripalimab, Paclitaxel, Cisplatin)

      Recruiting
      • Esophageal Squamous Cell Cancer
      • Beijing, Beijing, China
        Beijing Cancer Hospital / Peking University Cancer Hospital
      Jan 30, 2023

      Esophageal Cancer Trial in Taoyuan (PET/MRI)

      Completed
      • Esophageal Cancer
      • PET/MRI
      • Taoyuan, Taiwan
        Linkou Chang Gung Memorial Hospital
      May 9, 2023

      Esophageal Squamous Cell Carcinoma Trial in Chongqing (Tislelizumab)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma
      • Chongqing, Chongqing, China
        Army Medical Center of the People's Liberation Army
      May 26, 2023

      Immunotherapy;Envafolimab; Esophageal Cancer Trial (Envafolimab, Abraxane, Cisplatin)

      Not yet recruiting
      • Immunotherapy;Envafolimab; Esophageal Cancer
      • (no location specified)
      Apr 24, 2023

      Minimally Residual of Esophageal Cancer 001

      Recruiting
      • Esophageal Carcinoma
      • Minimal Residual Disease
        • Shijiazhuang, Hebei, China
          Fourth Hospital of Hebei Medical University
        Jul 17, 2023

        Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to

        Active, not recruiting
        • Esophageal Cancer
        • follow up
        • Guangzhou, Guangdong, China
          Jianhua Fu
        Sep 24, 2023

        Esophageal Cancer Trial in Moscow (Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.,

        Recruiting
        • Esophageal Cancer
        • Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.
        • Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy
        • Moscow, Russian Federation
          N.N. Blokhin National Medical Research Center of Oncology
        Oct 2, 2022

        Esophageal Cancer Trial (Hypofractionated radiotherapy)

        Not yet recruiting
        • Esophageal Cancer
        • Hypofractionated radiotherapy
        • (no location specified)
        Jan 18, 2023

        Surgical Procedure, Unspecified Trial in Shanghai (ROBOTIC-ASSISTED ESOPHAGECTOMY)

        Not yet recruiting
        • Surgical Procedure, Unspecified
        • ROBOTIC-ASSISTED ESOPHAGECTOMY
        • Shanghai, China
          Shanghai Chest Hospital, Shanghai Jiao Tong University
        Aug 21, 2023

        Esophageal Tumor Trial in China (cisplatin and paclitaxel)

        Completed
        • Esophageal Neoplasm
        • cisplatin and paclitaxel
        • Beijing, Beijing, China
        • +8 more
        Oct 3, 2022

        Oncology Trial in Nijmegen (combined aerobic exercise + resistance exercise intervention (AE + RE), Aerobic exercise prior to

        Recruiting
        • Oncology
        • combined aerobic exercise + resistance exercise intervention (AE + RE)
        • Aerobic exercise prior to daily radiotherapy sessions (ExPR)
        • Nijmegen, Gelderland, Netherlands
          Radboud Institute for Health Science
        Jan 8, 2023

        Esophageal Cancer, Esophageal Tumors Trial in Milano (hybrid PET/MRI)

        Recruiting
        • Esophageal Cancer
        • Esophageal Neoplasms
        • hybrid PET/MRI
        • Milano, Italy
          Deaprtment of Radiology, IRCCS Ospedale San Raffaele
        Jan 24, 2023

        Esophagus Cancer Trial in Xiamen (Tislelizumab, Paclitaxel-albumin, Carboplatin)

        Recruiting
        • Esophagus Cancer
        • Xiamen, Fujian, China
          ShanghaiZhongshan
        Apr 8, 2023

        Esophageal Cancer Trial in Rotterdam (Nivolumab)

        Not yet recruiting
        • Esophageal Cancer
        • Rotterdam, Netherlands
          Erasmus MC
        Aug 4, 2022

        The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer

        Recruiting
        • Breast Cancer
        • Standard Therapy
        • Shenyang, Liaoning, China
          Shengjing Hospital of China Medical University
        Jul 30, 2022

        Esophageal Squamous Cell Carcinoma Trial in Nanjing (Sintilimab, Liposomal Paclitaxel + Cisplatin + S-1)

        Active, not recruiting
        • Esophageal Squamous Cell Carcinoma
        • Nanjing, Jiangsu, China
          The First Affiliated Hospital with Nanjing Medical University
        Jul 16, 2022

        Advanced Esophageal Squamous Cell Cancer Trial in Jinan (Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy)

        Recruiting
        • Advanced Esophageal Squamous Cell Cancer
        • Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy
        • Jinan, Shandong, China
          Shandong Cancer Hospital and Institute
        Apr 11, 2022

        Neoadjuvant Chemotherapy Compared With Surgery for Esophageal

        Completed
        • Esophagus Cancer
        • Paclitaxel- and platinum-based chemotherapy
        • Zhengzhou, Henan, China
          Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
        Oct 5, 2022

        Artificial Intelligence and Cancer Staging in Upper

        Recruiting
        • Gastrointestinal Cancer
          • VAN, Turkey
            Van Yuzuncu Yil University
          Jan 3, 2023

          Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Toripalimab, Paclitaxel-albumin, Nedaplatin)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • Guangzhou, Guangdong, China
            Sun yat-sen University Cancer Center
          Oct 25, 2022

          Esophageal Carcinoma Trial in Tianjin (camrelizumab)

          Recruiting
          • Esophageal Carcinoma
          • Tianjin, China
            Tianjin Medical University Cancer Institute & Hospital
          Jul 25, 2022

          Esophageal Cancer, Active Surveillance, Neoadjuvant Chemoradiotherapy Trial in Rotterdam (Active surveillance)

          Active, not recruiting
          • Esophageal Cancer
          • +3 more
          • Active surveillance
          • Rotterdam, Zuid-Holland, Netherlands
            Erasmus MC, University Medical Center
          Jul 11, 2023